111 related articles for article (PubMed ID: 9007851)
21. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
Dunn SM; Bladen C
Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
[TBL] [Abstract][Full Text] [Related]
23. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
24. Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells.
Mihara S; Fujimoto M
Jpn J Pharmacol; 1991 Jul; 56(3):249-59. PubMed ID: 1832726
[TBL] [Abstract][Full Text] [Related]
25. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 312():86-103. PubMed ID: 1663336
[TBL] [Abstract][Full Text] [Related]
26. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
Salomone S; Godfraind T
Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
[TBL] [Abstract][Full Text] [Related]
27. In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818.
Hattori Y; Fukao M; Houzen H; Qi F; Yamada Y; Kanno M
Eur J Pharmacol; 1996 Apr; 301(1-3):99-106. PubMed ID: 8773452
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
Maan AC; Hosey MM
Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
[TBL] [Abstract][Full Text] [Related]
30. Calciseptine binding to a 1,4-dihydropyridine recognition site of the L-type calcium channel of rat synaptosomal membranes.
Yasuda O; Morimoto S; Chen Y; Jiang B; Kimura T; Sakakibara S; Koh E; Fukuo K; Kitano S; Ogihara T
Biochem Biophys Res Commun; 1993 Jul; 194(2):587-94. PubMed ID: 8393668
[TBL] [Abstract][Full Text] [Related]
31. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries.
Karasawa A; Kubo K
Jpn J Pharmacol; 1988 May; 47(1):35-44. PubMed ID: 3411819
[TBL] [Abstract][Full Text] [Related]
32. Interaction of lacidipine with its receptor binding site supports a slow onset and long duration of action.
Graziani F; Ratti E; van Amsterdam FT
J Cardiovasc Pharmacol; 1996 Feb; 27(2):290-6. PubMed ID: 8720430
[TBL] [Abstract][Full Text] [Related]
33. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
Kozlowski R; Ehrhard P; Fischli W; Osterrieder W; Holck M
J Pharmacol Exp Ther; 1986 Sep; 238(3):1084-91. PubMed ID: 2427686
[TBL] [Abstract][Full Text] [Related]
34. A new Ca-antagonist, CD-349, binding to the Ca-channel of rat myocardium and brain and hog coronary artery.
Muramatsu M; Fujita-Tominaga A; Tanaka M; Ishii Y; Aihara H
Jpn J Pharmacol; 1988 Dec; 48(4):453-62. PubMed ID: 2854176
[TBL] [Abstract][Full Text] [Related]
35. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle.
Latifpour J; Yoshida M; Weiss RM
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):679-87. PubMed ID: 1386146
[TBL] [Abstract][Full Text] [Related]
37. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.
Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM
J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacological profile of F-0401, a novel dihydropyridine derivative. (1) Mechanisms of action].
Kase N; Takasaki K; Higashide Y; Tamura N; Lee B; Yamaura T; Ohnishi H
Nihon Yakurigaku Zasshi; 1993 Jun; 101(6):363-74. PubMed ID: 8340021
[TBL] [Abstract][Full Text] [Related]
39. In vivo measurement of 1,4-dihydropyridine receptors in mesenteric arteries of spontaneously hypertensive rats and effect of nifedipine and cilnidipine.
Nakajima M; Yamada S; Uchida S; Kimura R
Biol Pharm Bull; 2002 Jan; 25(1):24-8. PubMed ID: 11824551
[TBL] [Abstract][Full Text] [Related]
40. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
Williams LT; Tremble P
J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
